Sydnexis Receives FDA Acceptance for SYD-101 New Drug Application for Pediatric Myopia
The low-dose atropine formulation could be the first approved drug in the United States to slow myopia in children. On…
Unblocking Tear Ducts: Pediatric Management and Complications
At the recently held 5th World Congress of Paediatric Ophthalmology and Strabismus (WCPOS V 2024), in Kuala Lumpur, Malaysia, delegates…
latest posts
